本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Precigen

1.55
-0.0100-0.64%
盤後1.580.0280+1.81%16:39 EDT
成交量:70.81萬
成交額:110.45萬
市值:4.56億
市盈率:-3.29
高:1.60
開:1.58
低:1.52
收:1.56
資料載入中...

公司資料

公司名字:
Precigen
交易所:
NASDAQ
成立時間:
1998
員工人數:
143
公司地址:
20374 Seneca Meadows Parkway,Germantown,Maryland,United States
郵編:
20876
電話:
傳真:
- -
簡介:
Precigen, Inc.成立於俄亥俄州有限責任公司。該公司於2004年重新註冊為弗吉尼亞州公司。Precigen, Inc.是合成生物學領域的領導者,合成生物學是一門新興且快速發展的學科,將工程原理應用於生物系統。該公司利用其專有和互補技術套件,設計、構建和調控基因程序,這些程序是由關鍵遺傳成分組成的DNA序列。

董事

名稱
職位
Randal J. Kirk
Director,Chief Executive Officer and Chairman
Cesar L. Alvarez
Director
Dean J. Mitchell
Director
Fred Hassan
Director
James S. Turley
Director
Jeffrey B. Kindler
Director
Robert B. Shapiro
Director
Steven Frank
Director
Vinita D. Gupta
Director

股東

名稱
職位
Randal J. Kirk
Director,Chief Executive Officer and Chairman
Thomas P. Bostick
Chief Operating Officer
Jeffrey T. Perez
Senior Vice President, Intellectual Property Affairs
Joel Liffmann
Senior Vice President, Finance
Rick L. Sterling
Chief Financial Officer
Robert F. Walsh, III
Senior Vice President, Energy & Fine Chemicals
Donald Lehr
Chief Legal Officer
Helen Sabzevari
President, Precigen, Inc.
Nir Nimrodi
Chief Business Officer
Thomas D. Reed
Founder and Chief Science Officer